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Serial Quantitative Assessment of
Absolute Coronary Flow and Flow Reserve
With CAD Progression to EventsStefano Sdringola, MD,* Nils P. Johnson, MD, MS,* Jagat Narula, MD, PHD,y
K. Lance Gould, MD*
A LARGE ATHEROSCLEROTIC PLAQUE BURDEN AND SEVERE LUMINAL STENOSIS ARE ASSO-
CIATED WITH UNFAVORABLE OUTCOMES IN CORONARY ARTERY DISEASE (CAD). On the one
hand, critical luminal obstruction has remained the gold standard for clinical decisions on coronary
revascularization. On the other hand, expansion of plaque volume has been proposed as a prerequisite
for acute coronary syndrome (ACS) events, including sudden death and acute myocardial infarction (MI)
(1). In this iPIX, we discuss serial assessment of absolute coronary ﬂow and coronary ﬂow reserve,
demonstrating the relationship between plaque progression by positron emission tomography (PET)
perfusion imaging and major adverse coronary events.
Traditional belief holds that plaques resulting in ACS are generally subcritically occluded. PROSPECT
(Providing Regional Observations to Study Predictors of Events in the Coronary Tree), a large,
multicenter serial imaging study, recently demonstrated substantial plaque expansion before the
occurrence of ACS. The fateful lesions evolved from 32  21% diameter stenosis to 65  16% over a
follow-up period of 3.4 years; intravascular ultrasound–veriﬁed cross-sectional plaque area burden
(>70%) and minimum luminal area (<4 mm2) were 2 (of the 3) most important determinants of
outcomes. Histopathological comparison of a large number of stable, vulnerable, and disrupted
plaques revealed that plaque rupture was associated with signiﬁcant luminal stenosis (1). In this
study, the plaques that ruptured were substantially more occlusive than the plaques vulnerable to
rupture. The authors therefore proposed that the high-risk plaques would need to expand further
before they ruptured.
For stable coronary disease, a critical severity threshold of luminal stenosis identiﬁes patients with
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Figure 1. Progression to Myocardial Infarction
A patient had normal ﬁndings on a rest/stress rubidium-82 positron emission tomography (PET) scan in 2004 when he was 52 years of age. He had sought medical
advice for atypical chest pain in the presence of numerous risk factors, including diabetes, hypertension, hypercholesterolemia, and a family history of premature
coronary artery disease. He did not return for follow-up or risk factor management until 2011. During routine follow-up, with the patient experiencing no angina or
cardiovascular symptoms, a PET scan performed in 2011 showed mild progression on relative tracer uptake on stress PET images. However, quantitative absolute
coronary ﬂow reserve (CFR) was severely reduced to 1.4, below the low-ﬂow threshold causing ischemia in the distribution of the left anterior descending coronary
artery (LAD). CFR in the rest of the heart averaged 2.3, indicating diffuse coronary atherosclerosis above the threshold for ischemia in addition to localized stenosis of
the proximal LAD. A computed tomography scan done for attenuation correction of PET images showed dense coronary calciﬁcation throughout the coronary tree. He
declined invasive procedures due to a lack of symptoms and did not undertake recommended risk factor control. Eight months later, he sustained a myocardial
infarction, and angiography showed severe multivessel disease, for which he underwent 4-vessel coronary bypass surgery. A single illustrative anterior view of 2
sequential relative stress images is shown. The color bar shows absolute CFR based on rest stress myocardial perfusion in milliliters per minute per gram for the second
PET scan. A generalized arterial map is superimposed on the initial images for orientation. D1 ¼ 1st diagonal branch; D2 ¼ 2nd diagonal branch; LCx ¼ left circumﬂex
artery; RI ¼ ramus intermedius.
Figure 2. Progression to Ventricular Tachycardia
Exertional angina developed in a 53-year-old patient with positive results on an exercise tolerance test. The angiogram showed multiple mild to moderate stenoses. He
chose strict risk factor management by diet, body weight, regular exercise, and lipid medications, with resolution of angina without invasive intervention. Risk factors
included hypertension and lipids of total cholesterol of 246 mg/dl, low-density lipoprotein level of 168 mg/dl, and high-density lipoprotein level of 50 mg/dl. After
starting statin therapy, the high-density lipoprotein level fell to 40, intermediate low-density lipoprotein particle size, for which nicotinic acid was added; lipids were
maintained at total cholesterol 142 mg/dl, low-density lipoprotein at 70 mg/dl (type A), high-density lipoprotein 59 mg/dl to the present. At 61 years of age, routine
PET relative uptake images using rubidium-82 showed no signiﬁcant regional stress-induced perfusion defects. The patient, without symptoms, underwent a routine
follow-up PET scan 3 years later that showed mild progression. Further routine PET follow-up at 6 years in the absence of angina showed more severe progression
associated with recurrent ventricular tachycardia during dipyridamole stress. Angiography showed signiﬁcant LAD stenosis, which was successfully stented, after which
the patient had an uneventful course. Strict risk factor control stabilized severe coronary atherosclerosis for 14 years before revascularization was needed based on PET
follow-up associated with stress-induced ventricular tachycardia. A single illustrative anterior view of stress images is shown. The color bar shows relative uptake. A
generalized arterial map is superimposed on the initial images for orientation. Abbreviations as in Figure 1.
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Figure 3. Progression to Severely Reduced CFR and Preventive PCI
The patient had chest pain with anterior myocardial infarction at 46 years of age, tissue plasminogen activator was administered within 1.5 h, ventricular
tachycardia/ventricular ﬁbrillation occurred during transport to the hospital emergency department; the patient underwent coronary artery bypass surgery with
4 grafts and had a subsequent benign course. Risk factors included hypercholesterolemia and a family history of coronary artery disease. Receiving statin and
extended-release niacin therapy, total cholesterol was maintained at 144 mg/dl, triglycerides at 29 mg/dl, low-density lipoprotein at 72 mg/dl, and high-density
lipoprotein at 66 mg/dl to the present. Repeat PET using rubidium-82 in 2007 at 60 years of age showed dense coronary calciﬁcations and no clinically
signiﬁcantly localized stress-induced defects on the relative uptake images. Quantitative absolute CFR was 3.8 in the diagonal distribution and slightly reduced
to 3 in the distribution of the LAD. In 2008, without symptoms, routine follow-up stress PET showed no clinically signiﬁcant stress defects on relative uptake
images, but CFR was diffusely further decreased to 2.2, indicating diffuse progression and early segmental stenosis, but ﬂow capacity remained above the
threshold for ischemia. In 2009, still without symptoms, further routine follow-up PET showed mild progression on relative uptake images. However, CFR was
progressively severely reduced to 1.5, indicating severe disease progression for which arteriography and stent placement were performed. Strict risk factor
control stabilized severe coronary atherosclerosis for 16 years before revascularization was needed based on quantitative PET follow-up. A single illustrative
anterior view of stress images is shown. The color bar shows absolute coronary ﬂow reserve determined from absolute myocardial perfusion at rest and stress.
Relative CFR that is the ﬂow-determined equivalent of pressure-based FFR on the 3 sequential stress scans is 0.9, 0.75, and 0.5 in the LAD region of the ﬁnal
perfusion defect. Abbreviations as in Figure 1.
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737based on routine measurement of fractional ﬂow reserve (FFR) in patients with multivessel CAD
improved outcomes compared with PCI based on the angiogram. In the original FAME (Fractional
Flow Reserve Versus Angiography for Multivessel Evaluation) trial, the patients randomly assigned to
FFR-guided PCI had a lower 2-year rate of death, MI, and need for repeat revascularization than
patients with angiographically guided PCI. In the logical extension of this study, the FAME II trial
established the superiority of an FFR-guided PCI strategy over optimal medical therapy in patients
with an FFR #0.8. Although designed for a follow-up of 2 years, enrollment in the FAME II trial was
terminated early due to substantial treatment difference. The difference in the composite endpoint
was predominantly driven by a signiﬁcantly lower rate of urgent revascularization in the PCI arm
(hazard ratio: 0.13; 95% conﬁdence interval: 0.06 to 0.30; p < 0.001). The need for an urgent
revascularization was not based on demonstration of ischemia or an increase in serum biomarkers,
and there were very few hard endpoints.
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738The facts presented here are based on a 1-time-point invasive assessment, serial intravascular
imaging, or postmortem analysis. It is reasonable to propose that a noninvasive imaging strategy
should provide prognostic information to help decide on timely interventions. For this iPIX,
several cases of serially assessing absolute coronary ﬂow and ﬂow reserve or relative stress
perfusion by PET show progression of CAD to an adverse event and/or indication for revascu-
larization (Figs. 1 to 3).Address for correspondence: Dr. K. Lance Gould, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of
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